STAT
SEPTEMBER 20, 2023
The federal government is again offering free Covid-19 tests to Americans, providing a fifth round of free tests in part to meet current needs, in part to stimulate a domestic testing industry that has struggled with cratering demand for the rapid diagnostics. The measure, announced Wednesday, will see rapid tests released from the Strategic National Stockpile.
PharmaVoice
SEPTEMBER 20, 2023
The saga of the anti-parasitic drug continues.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 20, 2023
More than three years into the coronavirus pandemic, fewer and fewer people are experiencing their first Covid-19 infections. But as cases climb , those who’ve had the virus before may wonder: What are their chances of developing long Covid — and does the risk increase with each reinfection? Fatigue and brain fog may be the first post-infection symptoms that come to mind for long Covid, but lists compiled by the Centers for Disease Control and Prevention and by the World Health Org
Pharma Times
SEPTEMBER 20, 2023
Around 340,000 to 444,000 people in the UK carry one of nine pathogenic gene variants - News - PharmaTimes
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
SEPTEMBER 20, 2023
Open wide, AI wants a look inside your mouth. A new wave of software is promising to supercharge dentists’ ability to spot decay and bone loss — and propose treatments earlier in the disease process. In just the past three years, eight AI products have gained approval from the Food and Drug Administration. Many more are on the way. These tools in some cases identify lesions years before dentists can see them on X-rays and other images, providing increased treatment opportunities ba
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
SEPTEMBER 20, 2023
As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. for selling unapproved versions of its Mounjaro diabetes drug, which is frequently used for combating obesity. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.
pharmaphorum
SEPTEMBER 20, 2023
Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals Phil.
STAT
SEPTEMBER 20, 2023
T wo months ago, Sen. Bernie Sanders (I-Vt.) moved a step closer to an idea he has championed for some time — awarding prizes, instead of patents, for inventing medicines. A measure was passed directing the National Academies of Sciences, Engineering, and Medicine to study the idea and was added to the Pandemic and All-Hazards Preparedness Act.
Pharmaceutical Technology
SEPTEMBER 20, 2023
The neurotech will receive the investment in Series B equity financing round to invest in Alzheimer’s disease research.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
SEPTEMBER 20, 2023
WASHINGTON — Roughly three-quarters of states have legalized marijuana either for medical or recreational use, but for years, cannabis users have been barred from getting jobs with the federal government. Congress inched closer Wednesday toward making it easier for those who smoke pot to become feds, but several Republicans used the moment to rail against the idea.
The Pharmacist
SEPTEMBER 20, 2023
More than 80,000 patients across mid and south Essex are now monitoring their blood pressure at home as part of an NHS scheme, according to a study by Essex University. BP@home, which was launched nationally in 2020, allows people to monitor their own blood pressure and submit readings to their GP by telephone and email […] The post Home blood pressure service 'success' in Essex appeared first on The Pharmacist.
STAT
SEPTEMBER 20, 2023
Difficulty scheduling an urgent or time-sensitive appointment is now the most common gripe my patients sound off about to my primary care colleagues and me. Our practice is not the exception — it has become the rule. A 2022 national survey showed that, on average, it takes 20.6 days to get a family medicine appointment. There are many reasons for this, including, most significantly, a shorthanded clinician workforce, with many physicians either leaving primary care or opting for models li
The Pharmacist
SEPTEMBER 20, 2023
A shortage of pharmacists and pharmacy technicians working in Scotland’s GP-based pharmacotherapy service needs to be urgently addressed, the Royal Pharmaceutical Society (RPS) director for Scotland has told The Pharmacist. Laura Wilson also highlighted the need for long-term workforce planning for pharmacy staff, akin to current work being done by the Scottish Government around planning […] The post Exclusive: Scotland’s pharmacotherapy service needs long-term workforce planning appeared
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
SEPTEMBER 20, 2023
ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set back with the agency requesting an additional study. Neffy, as the product is called, is a nasal spray that delivers the same drug, epinephrine, as the auto-injectors currently used to treat anaphylaxis.
pharmaphorum
SEPTEMBER 20, 2023
The evolution of computer validation from being on premises to being hosted in the cloud Mike.
STAT
SEPTEMBER 20, 2023
Apellis Pharmaceuticals has been slowly rebounding from an unjustified safety scare related to its approved treatment for a common type of vision loss. Now, a competing medicine from Astellas, also recently approved, may have stumbled, which could further boost Apellis’ business outlook — and its stock price. In a statement released Monday night, Astellas announced the “positive” outcome of an important follow-up analysis meant to demonstrate the two-year efficacy of
BioPharma Dive
SEPTEMBER 20, 2023
Targeted protein degradation has emerged as one of the more competitive areas of pharmaceutical research in recent years as scientists develop new ways to reach difficult-to-drug targets.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
STAT
SEPTEMBER 20, 2023
Americans who suffer severe allergic reactions won’t have alternatives to autoinjectors like the Epipen for a while longer. In a surprise move, the Food and Drug Administration on Tuesday declined to approve neffy , an epinephrine nasal spray. Instead, the FDA asked the drug’s manufacturer, ARS Pharma, to conduct further studies, specifically comparing the effect of repeat doses of epinephrine administered via nasal spray versus auto-injection in people with allergic rhinitis, or h
PharmExec
SEPTEMBER 20, 2023
The current vaccine pipeline brings promise of significant global health advancements—yet development gaps remain, and the future delivery challenges must be considered.
STAT
SEPTEMBER 20, 2023
Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI , they say. In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electro
Express Pharma
SEPTEMBER 20, 2023
Biocon Biologics has received the European Commission (EC) granted marketing authorization in the European Union (EU) for YESAFILI, a biosimilar of Aflibercept. The EC decision follows the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) positive opinion recommending approval of YESAFILI in July. YESAFILI , an ophthalmology product, is intended for the treatment of neovascular (wet AMD) age-related macular degeneration, visual impairment due to macular oedema sec
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
STAT
SEPTEMBER 20, 2023
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Enough talk about fairness, safety, and effectiveness. If we want AI systems to possess these attributes in health care, we have to test them with those goals in mind.
Express Pharma
SEPTEMBER 20, 2023
Eli Lilly received approval for its dual glucagon-like peptide-1 receptor agonist (GLP-1)/gastric inhibitor polypeptide receptor agonist (GIP) therapy Mounjaro (tirzepatide) in August 2023 for use as a new treatment option for patients in England with type 2 diabetes (T2D), in cases where the existing treatment management options are insufficient. With the recent clinical data that has come out of both the SURMOUNT and SURPASS trials for both T2D and obesity, it is likely that Mounjaro will beco
STAT
SEPTEMBER 20, 2023
For the fourth time this year, Novartis has been reprimanded by a U.K. trade group for misleading promotional efforts for its biggest-selling drug and, in the process, failing to maintain high standards expected of pharmaceutical companies. In the latest instance, the company was cited for hosting an online event to discuss heart failure but the virtual meeting essentially amounted to a promotional event, since Novartis medicines — specifically, the Entresto heart failure treatment ȁ
pharmaphorum
SEPTEMBER 20, 2023
DeepMind applies its AI expertise to genetic diseases Phil.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
SEPTEMBER 20, 2023
Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today is chocolate raspberry — and get started. To help you along, we have assembled another menu of tidbits for you to peruse.
Express Pharma
SEPTEMBER 20, 2023
The National Company Law Appellate Tribunal (NCLAT), Delhi has delivered its decision regarding the contentious insolvency case concerning Hindustan National Glass. The NCLAT has upholded the entire insolvency resolution process followed by the Resolution Professional and endorsed by the Committee of Creditors (COC). This ruling follows a series of appeals brought before the NCLAT by various parties such as Independent Sugar Corporation and others.
STAT
SEPTEMBER 20, 2023
Northeastern University has been selected for a leading role in a new national network formed to better forecast the spread of a future pandemic. The university announced Tuesday the US Centers for Disease Control and Prevention has awarded it $17.5 million over the next five years to develop a center focused on detecting and preparing for the next outbreak of infectious disease, especially in rural areas.
Expert insights. Personalized for you.
364 
Let's personalize your content